As the international community struggles to mobilize funds and resources to take on the Zika virus outbreak, pandemic experts have asked why the private sector has not played a bigger role in critical elements of response such as diagnostic testing.
But that could change soon.
“We really don’t have a good test and we don’t so far have a lot of private sector partners who are ready to scale up the technology to make diagnostic tests,” Patrick Kachur, medical officer at the U.S. Centers for Disease Control and Prevention said at the Center for Strategic and International Studies in Washington, D.C., on Thursday.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Jeff Tyson@jtyson21
Jeff is a former global development reporter for Devex. Based in Washington, D.C., he covers multilateral affairs, U.S. aid, and international development trends. He has worked with human rights organizations in both Senegal and the U.S., and prior to joining Devex worked as a production assistant at National Public Radio. He holds a master's degree in journalism from Columbia University and a bachelor’s degree in international relations and French from the University of Rochester.
